Log in to save to my catalogue

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a...

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d00f5ace3a3b4b0188bbbc3e79373034

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs

About this item

Full title

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs

Publisher

Cambridge: Cambridge University Press

Journal title

Journal of clinical and translational science, 2020-06, Vol.4 (s1), p.73-73

Language

English

Formats

Publication information

Publisher

Cambridge: Cambridge University Press

More information

Scope and Contents

Contents

OBJECTIVES/GOALS: This study aims to assess the outcomes of a new virtual multidisciplinary immune-related toxicity (IR-tox) team implemented at Johns Hopkins Hospital. In particular, to understand if the IR-tox team’s input reduced the number of inpatient hospitalizations for irAEs for referred patients. METHODS/STUDY POPULATION: Since August 2017...

Alternative Titles

Full title

4401 Incidence, management, and outcomes of immune-related adverse events (irAEs): an analysis of a multidisciplinary toxicity team for cancer immunotherapy related irAEs

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d00f5ace3a3b4b0188bbbc3e79373034

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d00f5ace3a3b4b0188bbbc3e79373034

Other Identifiers

ISSN

2059-8661

E-ISSN

2059-8661

DOI

10.1017/cts.2020.239

How to access this item